Psoriasis, biologic therapy, and the pandemic of the 21st century
This editorial discusses the impact of COVID-19 on patients with psoriasis receiving biologic agents.
This editorial discusses the impact of COVID-19 on patients with psoriasis receiving biologic agents.
This editorial discusses the current COVID-19 outbreak and underlines that hygienic educational programs are fundamental and must be continued and implemented especially for immunosuppressed children.
This review aims to present the available in vitro and in vivo data for the role of chloroquine/ hydroxychloroquine in COVID-19 and attempts to put them into perspective, especially in relation to the different risks/benefits particular to each patient who may require treatment.
This review discusses antiretroviral therapy and its nephrotoxic effects, including drug–drug interactions. It aims to guide the clinician on dose adjustment in the setting of renal impairment and dialysis, for the commonly used drugs in patients with HIV.